Sensome

medical devices

About

Sensome is a clinical-stage health technology company founded in 2014 as a spin-off from CNRS and Ecole polytechnique in France. The company focuses on developing micro-sensor technology that enhances invasive medical devices by integrating impedance-based micro-sensors with machine learning algorithms. This technology allows for real-time identification of biological tissues, improving clinical decision-making. The flagship product, Clotild®, is a connected guidewire designed for treating acute ischemic stroke. It analyzes blood clot content during mechanical thrombectomy procedures, helping physicians choose the best tools and strategies for effective clot removal. Sensome's technology has potential applications beyond stroke treatment, including oncology and peripheral artery disease (PAD). The company has secured significant funding, including a $9 million Series B round, to advance its technology and bring Clotild® to market. Sensome collaborates with Asahi Intecc to develop new connected guidewires, combining their sensor technology with Asahi's expertise.

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Wix YouTube Varnish Mobile Friendly Remote AI

Keywords

medical devices connected objects medtech neurovascular medical health care oncology tumor confirmation system neurointerventional technology medical technology peripheral artery disease machine learning in healthcare healthcare equipment & supplies manufacturing healthcare technology impedance spectroscopy stroke intervention technology stroke guidewire b2b predictive reliability peripheral artery disease treatment ai-powered medical devices digital health tissue recognition impedance-based sensors cardiology interventional neuroradiology machine learning real-time monitoring micro-sensors medical device innovation

Location

2 Rue du Chemin des Femmes, Massy, Ile-de-France, France, 91300

Related Companies

Companies in the same industry